Drug profile · INN
ripretinib
QINLOCK
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
ripretinib (QINLOCK) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN ripretinib
Brand QINLOCK
Route ORAL
Formulation TABLET
ATC code L01
Frequently asked questions
What is ripretinib?
ripretinib (QINLOCK) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ripretinib?
QINLOCK is a marketed brand name for ripretinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ripretinib?
ripretinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.